Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -8.00 (-3.48%)
Bid:
215.00
Ask:
227.00
Spread: 12.00 (5.581%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Trading Update and Board Changes

22 Oct 2015 07:00

RNS Number : 0335D
Microgen PLC
22 October 2015
 



microgen

www.microgen.com 22 October 2015

 

 

MICROGEN PLC

("MICROGEN" or "GROUP")

 

TRADING UPDATE AND BOARD CHANGES

 

 

Trading Update

 

The Group's Aptitude Software and Financial Systems businesses continue to perform in line with the Board's expectations. Consistent with this stage of the financial year, 95% of total expected revenue for 2015 is now contracted. High forward revenue visibility is a benefit of the Group's annual licensing model.

 

Appointments and Board Structure

 

Microgen is pleased to announce the appointment of Ivan Martin to the Board. Mr Martin will initially join the Board as a Non-Executive Director and Chairman Designate on 1 January 2016 before assuming the role of Non-Executive Chairman after the release of the 2015 Results.

 

Mr Martin (60) will chair the Nomination Committee and be a member of the Audit and Remuneration Committees. Mr Martin is currently Non-Executive Chairman of both FDM Group plc and Red Topco Limited (trading as Red), a specialist SAP-based IT services business. Previously Mr Martin was a member of Misys plc's board and headed their banking software division until 2005. Between 2007 and 2013, he was Executive Chairman of Sesame Bankhall Group and Non-Executive Director of Avelo.

 

The Managing Directors of the Group's two operating businesses have been attending Board Meetings by invitation since 2013 and will formally join the Board on 1 January 2016. Simon Baines (44) joined Microgen in 2010 as Managing Director of the Financial Systems business, prior to which he worked in private equity covering financial services technology companies. Tom Crawford (47) joined Microgen in 2003 and was appointed Head of Aptitude Software USA operations in 2010 before being promoted to Managing Director of Aptitude Software in 2013, a role that divides his time between Boston and London.

 

Martyn Ratcliffe, will step down as Chairman and as a Director after the release of the 2015 Results allowing a smooth transition to Mr Martin.

 

Regulatory Information - Ivan Martin

 

As at 21 October 2015 Mr Martin does not currently have any interest in any ordinary shares in Microgen. Mr Martin is Non-Executive Chairman of FDM Group plc.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Martin.

 

Regulatory Information - Simon Baines

 

As at 21 October 2015 Mr Baines is the beneficial owner of 9,523 ordinary shares in Microgen and has an interest in 650,000 unvested share options.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Baines.

 

Regulatory Information - Tom Crawford

 

As at 21 October 2015 Mr Crawford is the beneficial owner of 129,551 ordinary shares in Microgen and has an interest in 650,000 unvested share options.

 

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13R relating to the appointment to the Board of Mr Crawford.

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Rowena Murray, Investec 020-7597-5970

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLRIVLLFIE
Date   Source Headline
24th Mar 201112:22 pmRNSAnnual Information Update
2nd Mar 201110:11 amRNSHolding(s) in Company
28th Feb 201110:15 amRNSTotal Voting Rights
25th Feb 201111:53 amRNSDirector/PDMR Shareholding
24th Feb 20117:00 amRNSFinal Results
16th Feb 20113:18 pmRNSNotice of Results
3rd Feb 20115:00 pmRNSHolding(s) in Company
3rd Feb 20114:58 pmRNSHolding(s) in Company
28th Jan 201112:59 pmRNSHolding(s) in Company
17th Jan 20114:18 pmRNSDirector Declaration
14th Jan 20114:18 pmRNSHolding(s) in Company
10th Jan 20117:00 amRNSPre-close Trading Update
7th Jan 201111:49 amRNSBlocklisting Return
7th Jan 201111:48 amRNSBlocklisting Return
4th Jan 201110:10 amRNSTotal Voting Rights
4th Nov 20107:00 amRNSDirector/PDMR Shareholding
3rd Nov 20103:40 pmRNSHolding(s) in Company
29th Oct 201010:00 amRNSTotal Voting Rights
26th Oct 20107:00 amRNSInterim Management Statement
26th Oct 20107:00 amRNSInterim Management Statement
30th Sep 20107:00 amRNSTotal Voting Rights
29th Sep 20108:05 amRNSDirector/PDMR Shareholding
27th Sep 20107:01 amRNSBlocklisting Interim Review
23rd Sep 201010:59 amRNSApplication for Blocklisting
15th Sep 20107:00 amRNSMicrogen Aptitude Modules Launch
9th Sep 20102:37 pmRNSHolding(s) in Company
6th Sep 201012:38 pmRNSHolding(s) in Company
2nd Sep 20104:32 pmRNSHolding(s) in Company
31st Aug 20101:19 pmRNSTotal Voting Rights
23rd Aug 20102:12 pmRNSDirector/PDMR Shareholding
23rd Aug 20107:00 amRNSResult of Tender Offer
19th Aug 201010:09 amRNSGM Announcement
11th Aug 201011:16 amRNSHolding(s) in Company
2nd Aug 20101:15 pmRNSPosting of Shareholder Circular
26th Jul 201012:49 pmRNSHolding(s) in Company
22nd Jul 20107:00 amRNSInterim Results
14th Jul 20103:30 pmRNSNotice of Results
1st Jul 201012:51 pmRNSBlocklisting Interim Review
1st Jul 201012:46 pmRNSBlocklisting Interim Review
24th Jun 20104:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20104:38 pmRNSHolding(s) in Company
1st Jun 20102:14 pmRNSDirector Declaration
4th May 20109:57 amRNSTotal Voting Rights
27th Apr 201012:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20102:41 pmRNSDirector/PDMR Shareholding
22nd Apr 20107:00 amRNSInterim Management Statement
16th Apr 20101:56 pmRNSDirector Declaration
22nd Mar 201010:03 amRNSAGM Statement
18th Mar 201011:33 amRNSAnnual Information Update
16th Mar 20105:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.